Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Pharma giant targets new standards of care
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Subscribe To Our Newsletter & Stay Updated